Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Yokoyama M, et al. Among authors: matsuzawa y. Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3. Lancet. 2007. PMID: 17398308 Clinical Trial.
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.
Yamamoto A, Arakawa K, Sasaki J, Matsuzawa Y, Takemura K, Tsushima M, Fujinami T, Mabuchi H, Itakura H, Yamada N, Toyota T, Oikawa S; Rosuvastatin Dose-Ranging Trialist Group. Yamamoto A, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2002;9(1):48-56. doi: 10.5551/jat.9.48. J Atheroscler Thromb. 2002. PMID: 12238638 Free article. Clinical Trial.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.
Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial. Matsuzaki M, et al. Among authors: matsuzawa y. Circ J. 2002 Dec;66(12):1087-95. doi: 10.1253/circj.66.1087. Circ J. 2002. PMID: 12499611 Free article.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial. Mabuchi H, et al. Among authors: matsuzawa y. Circ J. 2002 Dec;66(12):1096-100. doi: 10.1253/circj.66.1096. Circ J. 2002. PMID: 12499612 Free article.
Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 1: influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men.
Yamamoto A, Temba H, Horibe H, Mabuchi H, Saito Y, Matsuzawa Y, Kita T, Nakamura H; Research Group on Serum Lipid Survey 1990 in Japan. Yamamoto A, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2003;10(3):165-75. doi: 10.5551/jat.10.165. J Atheroscler Thromb. 2003. PMID: 14564086 Free article.
Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 2: association of lipid parameters with hypertension.
Yamamoto A, Temba H, Horibe H, Mabuchi H, Saito Y, Matsuzawa Y, Kita T, Nakamura H; Research Group on Serum Lipid Survey 1990 in Japan. Yamamoto A, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2003;10(3):176-85. doi: 10.5551/jat.10.176. J Atheroscler Thromb. 2003. PMID: 14564087 Free article.
Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan.
Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T; Research Committeon Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Bujo H, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2004;11(3):146-51. doi: 10.5551/jat.11.146. J Atheroscler Thromb. 2004. PMID: 15256765 Free article.
Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Horiuchi H, et al. Among authors: matsuzawa y. J Am Geriatr Soc. 2004 Dec;52(12):1981-7. doi: 10.1111/j.1532-5415.2004.52552.x. J Am Geriatr Soc. 2004. PMID: 15571531
Serum lipid survey and its recent trend in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T. Arai H, et al. Among authors: matsuzawa y. J Atheroscler Thromb. 2005;12(2):98-106. doi: 10.5551/jat.12.98. J Atheroscler Thromb. 2005. PMID: 15942120 Free article.
1,312 results